- CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test
- Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib
- Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension
- Tempus Announces Pricing of Initial Public Offering
Key statistics
On Tuesday, Tempus AI Inc (TEM:NSQ) closed at 35.98, -18.00% below its post-IPO high of 43.88, set on Jun 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 34.45 |
---|---|
High | 36.34 |
Low | 33.74 |
Bid | 36.05 |
Offer | 37.44 |
Previous close | 35.98 |
Average volume | 1.93m |
---|---|
Shares outstanding | 164.83m |
Free float | 70.40m |
P/E (TTM) | -- |
Market cap | 5.93bn USD |
EPS (TTM) | -1.78 USD |
Data delayed at least 15 minutes, as of Jul 02 2024 21:00 BST.
More ▼